317 related articles for article (PubMed ID: 34575464)
1. Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade.
Shoari A; Tooyserkani R; Tahmasebi M; Löwik DWPM
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575464
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.
Guo Z; Peng H; Kang J; Sun D
Biomed Rep; 2016 May; 4(5):528-534. PubMed ID: 27123243
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides for sustainable agriculture.
Patel P; Benzle K; Pei D; Wang GL
Trends Plant Sci; 2024 Jun; ():. PubMed ID: 38902122
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
Dowaidar M
Mitochondrion; 2024 May; 78():101906. PubMed ID: 38797356
[TBL] [Abstract][Full Text] [Related]
5. Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.
Xie J; Bi Y; Zhang H; Dong S; Teng L; Lee RJ; Yang Z
Front Pharmacol; 2020; 11():697. PubMed ID: 32508641
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Properties of Cell-Penetrating Peptides: Applications and Skin Penetration Mechanisms.
Shin HJ; Lee BK; Kang HA
ACS Appl Bio Mater; 2024 Jan; 7(1):1-16. PubMed ID: 38079575
[TBL] [Abstract][Full Text] [Related]
7. Cell Penetrating Peptides, Novel Vectors for Gene Therapy.
Taylor RE; Zahid M
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32138146
[TBL] [Abstract][Full Text] [Related]
8. Cell-Penetrating Peptides for Antiviral Drug Development.
Delcroix M; Riley LW
Pharmaceuticals (Basel); 2010 Mar; 3(3):448-470. PubMed ID: 27713263
[TBL] [Abstract][Full Text] [Related]
9. Boronic Acid-Linked Cell-Penetrating Peptide for Protein Delivery.
Ghosh P
ACS Omega; 2024 Apr; 9(17):19051-19056. PubMed ID: 38708278
[TBL] [Abstract][Full Text] [Related]
10. Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides.
Bonduelle CV; Gillies ER
Pharmaceuticals (Basel); 2010 Mar; 3(3):636-666. PubMed ID: 27713272
[TBL] [Abstract][Full Text] [Related]
11. Reinventing Cell Penetrating Peptides Using Glycosylated Methionine Sulfonium Ion Sequences.
Kramer JR; Schmidt NW; Mayle KM; Kamei DT; Wong GC; Deming TJ
ACS Cent Sci; 2015 May; 1(2):83-8. PubMed ID: 27162954
[TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery of fluorescent protein into viable wheat microspores using cationic peptides.
Bilichak A; Luu J; Eudes F
Front Plant Sci; 2015; 6():666. PubMed ID: 26379691
[TBL] [Abstract][Full Text] [Related]
13. Activatable cell-penetrating peptides: 15 years of research.
de Jong H; Bonger KM; Löwik DWPM
RSC Chem Biol; 2020 Oct; 1(4):192-203. PubMed ID: 34458758
[TBL] [Abstract][Full Text] [Related]
14. Automated high-content imaging for cellular uptake, from the Schmuck cation to the latest cyclic oligochalcogenides.
Martinent R; López-Andarias J; Moreau D; Cheng Y; Sakai N; Matile S
Beilstein J Org Chem; 2020; 16():2007-2016. PubMed ID: 32831957
[TBL] [Abstract][Full Text] [Related]
15. Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery.
Wang L; Geng J; Wang H
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):614-629. PubMed ID: 38481692
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
Zorko M; Jones S; Langel Ü
Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptides: Highlighting points in cancer therapy.
Asrorov AM; Wang H; Zhang M; Wang Y; He Y; Sharipov M; Yili A; Huang Y
Drug Dev Res; 2023 Sep; 84(6):1037-1071. PubMed ID: 37195405
[TBL] [Abstract][Full Text] [Related]
18. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic nanocarriers loaded with temozolomide by cloaking brain-targeting peptides for targeting drug delivery system to promote anticancer effects in glioblastoma cells.
Chen H; Wang Y; Wang H; Zhang K; Liu Y; Li Q; Li C; Wen Z; Chen Z
Heliyon; 2024 Apr; 10(7):e28256. PubMed ID: 38596030
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma.
Budka J; Debowski D; Mai S; Narajczyk M; Hac S; Rolka K; Vrettos EI; Tzakos AG; Inkielewicz-Stepniak I
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
